共 186 条
[1]
Cooper DS(2009)Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167-1214
[2]
Doherty GM(2012)Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation Ann Nucl Med 26 311-318
[3]
Haugen BR(2008)Follow up approaches in thyroid cancer: a risk adapted paradigm Endocrinol Metab Clin North Am 37 419-435
[4]
Kloos RT(2013)Long-term follow-up of patients with differentiated thyroid cancer who had negative 131I whole-body scan at first evaluation after treatment Clin Nucl Med 38 765-769
[5]
Lee SL(2011)Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients Eur J Endocrinol 165 441-446
[6]
Mandel SJ(2010)No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer Eur J Nucl Med Mol Imaging 37 276-283
[7]
Hong CM(2014)Differentiated thyroid carcinoma: an analysis of 249 patients undergoing therapy and aftercare at a single institution Clin Nucl Med 39 142-146
[8]
Ahn BC(2012)Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer Ann Nucl Med 26 777-786
[9]
Park JY(2012)Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy Clin Endocrinol (Oxf) 77 132-138
[10]
Jeong SY(2012)Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal Clin Endocrinol (Oxf) 76 734-740